Skip to main content

Find Clinical Trials

Home
Conditions
Secondary Hyperparathyroidism

Clinical trial condition

Secondary Hyperparathyroidism

Explore clinical trials studying Secondary Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

99 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Secondary Hyperparathyroidism trial results

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

NCT01653379

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: Tucson, Arizona, United States

Tustin, California, United States

Denver, Colorado, United States

St Louis, Missouri, United States

View Trial Details

Completed

Phase 3 Study of KHK7580

NCT02549404

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan

View Trial Details

Completed

Phase 3 Study of KHK7580

NCT02549417

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan

View Trial Details

Completed

Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

NCT03137316

Conditions: Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, +11 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

NCT01254565

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: Azusa, California, United States

Costa Mesa, California, United States

Lynwood, California, United States

Riverside, California, United States

View all 13 locations

View Trial Details

Completed

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

NCT01414114

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +25 more
Locations: Not specified

View Trial Details

Completed

Phase 3 Study of KHK7580

NCT02549391

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin Tokyo, Japan

View Trial Details

Completed

Trial to Optimize Mineral Outcomes in Dialysis Patients

NCT01100723

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +16 more
Locations: Lynchburg Nephrology Associates, P.L.L.C. Lynchburg, Virginia, United States

View Trial Details

Completed

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

NCT01219855

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +17 more
Locations: OPKO Health, Inc Bannockburn, Illinois, United States

View Trial Details

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

NCT00828347

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: Kumamoto University Hospital Kumamoto, Japan

View Trial Details